Trials / Completed
CompletedNCT04094545
Intestinal Flora Sequencing for Nasopharyngeal Carcinoma
Intestinal Flora Disruption and a Novel Intestinal Biomarker Associated With Nasopharyngeal Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 568 (actual)
- Sponsor
- The Third Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study investigated the correlation between the changes in the intestinal flora and NPC by an examination of the intestinal flora and multiple clinical indicators of the blood of 8 carefully screened patients of familial NPC, 24 patients of sporadic NPC and 27 healthy controls and a comparison of the differences in their intestinal flora structures and biological functions. By analyzing the function of the intestinal floras of NPC patients, we aimed to provide a better biological marker for patients with familial and sporadic NPC and constructed a disease prediction model for high-risk populations.
Detailed description
Nasopharyngeal carcinoma (NPC) is a malignant nasopharyngeal disease with a complicated etiology that occurs mostly in southern China. Intestinal flora imbalance is believed to be associated with a variety of organ malignancies. Currently, the relationship between intestinal flora and NPC is not clear, although many studies have shown that intestinal flora can be used as a biomarker for many cancers and to predict cancer. To compare the differences in intestinal flora compositions and biological functions among patients with familial NPC (NPC\_F), patients with sporadic NPC (NPC\_S) and healthy controls (NOR), we compared the intestinal flora DNA sequencing and hematological testing results between every two groups using bioinformatic methods.
Conditions
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2018-12-31
- Completion
- 2019-05-30
- First posted
- 2019-09-19
- Last updated
- 2019-09-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04094545. Inclusion in this directory is not an endorsement.